Patents by Inventor Daniel Frigo

Daniel Frigo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CaMKK-? as a target for treating cancer
    Patent number: 9999620
    Abstract: Provided herein are compounds, compositions, including pharmaceutical compositions, having anti-cancer activity. Also provided are methods for diagnosing, detecting, and treating cancer in a subject, as well as a method for evaluating cancer stage in a subject, wherein the methods include determining the amount of a Ca2+/calmodulin dependent kinase kinase (CaMKK) in a sample. Further provided are methods of screening and identifying a compound that inhibits CaMKK.
    Type: Grant
    Filed: June 17, 2016
    Date of Patent: June 19, 2018
    Assignee: Duke University
    Inventors: Donald P. McDonnell, Daniel Frigo, Anthony R. Means
  • CAMKK-BETA AS A TARGET FOR TREATING CANCER
    Publication number: 20170027928
    Abstract: Provided herein are compounds, compositions, including pharmaceutical compositions, having anti-cancer activity. Also provided are methods for diagnosing, detecting, and treating cancer in a subject, as well as a method for evaluating cancer stage in a subject, wherein the methods include determining the amount of a Ca2+/calmodulin dependent kinase kinase (CaMKK) in a sample. Further provided are methods of screening and identifying a compound that inhibits CaMKK.
    Type: Application
    Filed: June 17, 2016
    Publication date: February 2, 2017
    Inventors: Donald P. McDonnell, Daniel Frigo, Anthony R. Means
  • CAMKK-BETA AS A TARGET FOR TREATING CANCER
    Publication number: 20130253035
    Abstract: Provided herein are compounds, compositions, including pharmaceutical compositions, having anti-cancer activity. Also provided are methods for diagnosing, detecting, and treating cancer in a subject, as well as a method for evaluating cancer stage in a subject, wherein the methods include determining the amount of a Ca2+/calmodulin dependent kinase kinase (CaMKK) in a sample. Further provided are methods of screening and identifying a compound that inhibits CaMKK.
    Type: Application
    Filed: August 16, 2011
    Publication date: September 26, 2013
    Applicant: Duke University
    Inventors: Donald P. McDonnell, Daniel Frigo, Anthony R. Means